Azacitidine API

Azacitidine API
Holiness Pharmaceutical Ltd is a trusted and leading supplier and exporter of Azacitidine API, delivering high-quality oncology APIs to pharmaceutical companies across 40+ international markets. Azacitidine is a hypomethylating anticancer agent extensively used in the treatment of myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML), positioning us as a reliable Azacitidine bulk API supplier from India.
Globally, Holiness Pharmaceutical is recognized among reputable Azacitidine API manufacturers, delivering high assay purity, stringent impurity control, excellent stability, and consistent process performance suitable for injectable oncology formulations. Our expertise in complex anticancer molecules makes us a dependable Pharmaceutical API exporter.
Our oncology API manufacturing facilities operate in strict compliance with international regulatory standards including:
➡ DCGI, WHO-GMP, US-FDA aligned, and cGMP guidelines,
ensuring validated synthesis routes, tight impurity profiling, moisture and stability control, and full pharmacopeial compliance for Azacitidine API.
We export Azacitidine API from India to Asia, Africa, Europe, the Middle East, North America, South America, and CIS regions, supporting formulation manufacturers producing life-saving anticancer therapies. Holiness Pharmaceutical is widely trusted as a bulk Azacitidine API supplier.
Holiness Pharmaceutical is one of the leading producers of Active Pharmaceutical Ingredients (APIs) and Intermediates, delivering GMP-compliant manufacturing systems, consistent batch quality, and globally accepted regulatory documentation as a certified Pharmaceutical API exporter specializing in oncology APIs.
Holiness Pharmaceutical Ltd manages the complete lifecycle of API development — including R&D innovation, complex oncology synthesis, commercial-scale manufacturing, HPAPI capabilities, and worldwide distribution of APIs and intermediates.
Holiness Pharmaceutical has established a strong presence in many countries including:
United States, Canada, United Kingdom, Germany, France, Netherlands, Italy, Spain, Australia, New Zealand, Slovakia, Estonia, Belarus, Ukraine, Iceland, Kazakhstan, Uzbekistan, Turkmenistan, Tajikistan, Kyrgyzstan, Georgia, Russia, Yemen, Saudi Arabia, UAE, Qatar, Kuwait, Oman, Bahrain, Turkey, Senegal, Ethiopia, Eswatini, Cameroon, Zambia, Mozambique, Angola, Zimbabwe, Malawi, Seychelles, South Africa, Nigeria, Kenya, Tanzania, Ghana, Egypt, Panama, Costa Rica, El Salvador, Mexico, Brazil, Argentina, Chile, Peru, Colombia, Afghanistan, Bhutan, Cambodia, Vietnam, Indonesia, Philippines, Malaysia, Thailand, South Korea, Japan, Paraguay, Bangladesh.
Send Inquiry
More products from Anti-Cancer/Oncology
| Product Name | CAS Number | Grade | Form | Actions |
|---|---|---|---|---|
Docetaxel API | 114977-28-5 | BP/USP | API Powder | View Product |
Azacitidine API | 320-67-2 | BP/USP | API Powder | View Product |
Carboplatin API | 41575-94-4 | BP/EP/USP | API Powder | View Product |
Carboplatin API | 41575-94-4 | BP/EP/USP | API Powder | View Product |
Cytarabine API | 147-94-4 | IP/BP/USP | API Powder | View Product |
Decitabine API | 2353-33-5 | BP/USP | API Powder | View Product |
Gemcitabine HCl API | 122111-03-9 | IP/BP/USP | API Powder | View Product |
Lenalidomide Analog API | 191732-72-6 | IH | API Powder | View Product |
Letrozole API | 112809-51-5 | IP/USP | API Powder | View Product |
Olaparib API | 763113-22-0 | IP/BP/USP | API Powder | View Product |